Innovative Technology ProTom International offers the Radiance 330® Proton Therapy System, which is compact, customizable, and capable of fitting into spaces where traditional systems cannot, presenting a unique selling point for clinics with space constraints or seeking flexible installation options.

Recent Product Launches The company recently introduced the Radiance 330-C and fixed-beam proton systems, demonstrating a commitment to expanding accessible proton therapy solutions and creating new sales opportunities for healthcare providers looking to upgrade or diversify their treatment offerings.

Strategic Partnerships ProTom’s collaborations, such as with Leo Cancer Care and Beyond Behnke’s LLC, highlight opportunities to co-develop integrated systems and expand market reach, which can be leveraged to target hospitals and clinics seeking turnkey or integrated proton therapy solutions.

Growing Market Presence With recent media coverage and industry partnerships, ProTom is strengthening its position in the healthtech space, making it a compelling choice for institutions aiming to adopt cutting-edge, flexible proton therapy technology in their cancer treatment programs.

Financial and Funding Support Having secured $30 million in funding and generating revenues between $25 and $50 million, ProTom demonstrates financial stability and growth potential, offering confidence to prospective clients and partners considering investment in their technology.